Anaesthesia and pain management in cerebral palsy
暂无分享,去创建一个
T. Brown | J. Nolan | C. Olesch | T C Brown | J Nolan | G A Chalkiadis | J Low | C A Olesch | G. Chalkiadis | J. Low
[1] A. Giesecke. Anesthesia for Orthopaedic Surgery , 1981 .
[2] H. Graham,et al. Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. , 2000 .
[3] S. Moorthy,et al. Resistance to vecuronium in patients with cerebral palsy. , 1991, Anesthesia and analgesia.
[4] C. Truwit,et al. Cerebral palsy: MR findings in 40 patients. , 1992, AJNR. American journal of neuroradiology.
[5] J. Demazière,et al. Flumazenil counteracts intrathecal baclofen-induced central nervous system depression in tetanus. , 1992, Anesthesiology.
[6] M. Yaster. Smith's Anesthesia for Infants and Children , 1991 .
[7] L. A. Koman,et al. Management of Cerebral Palsy with Botulinum‐A Toxin: Preliminary Investigation , 1993, Journal of pediatric orthopedics.
[8] P. Deluca,et al. The musculoskeletal management of children with cerebral palsy. , 1996, Pediatric clinics of North America.
[9] A. L. Albright. Spastic Cerebral Palsy , 1995 .
[10] M. Pranzatelli. Oral Pharmacotherapy for the Movement Disorders of Cerebral Palsy , 1996, Journal of child neurology.
[11] A. L. Albright. Intrathecal Baclofen in Cerebral Palsy Movement Disorders , 1996, Journal of child neurology.
[12] C. Gomar,et al. Delayed arousal after general anesthesia associated with baclofen. , 1994, Anesthesiology.
[13] A. Duhaime,et al. Use of epidural morphine for control of postoperative pain in selective dorsal rhizotomy for spasticity. , 1989, Pediatric neuroscience.
[14] S. Goepferd,et al. TEMPOROMANDIBULAR JOINT CONTRACTURE IN SPASTIC QUADRIPLEGIA: EFFECT ON ORAL‐MOTOR SKILLS , 1994, Developmental medicine and child neurology.
[15] P. Carlen,et al. Pre- and postsynaptic effects of baclofen in the rat hippocampal slice , 1985, Brain Research.
[16] Munn Sann Lye,et al. Parenting stress among mothers of Malaysian children with cerebral palsy: predictors of child- and parent-related stress. , 1998, Annals of tropical paediatrics.
[17] P. Grimaud. [Cerebral palsy]. , 1972, Pediatrie.
[18] C. Chabal,et al. Development of an acute withdrawal syndrome following the cessation of intrathecal baclofen in a patient with spasticity. , 1992, Anesthesiology.
[19] R. Brunner,et al. Minimum alveolar concentration for halothane in children with cerebral palsy and severe mental retardation , 1997, Anaesthesia.
[20] B. Giusiano,et al. Utilization of a Neural Network in the Elaboration of an Evaluation Scale for Pain in Cerebral Palsy , 1995, Methods of Information in Medicine.
[21] K. Nelson,et al. Birth asphyxia and the neonatal brain: what do we know and when do we know it? , 1993, Clinics in perinatology.
[22] D. Glass. Anesthesia for Orthopaedic Surgery , 1980 .
[23] L. Mutch,et al. Cerebral Palsy Epidemiology: Where are We Now and Where are We Going? , 1992, Developmental medicine and child neurology.
[24] G. Krishna,et al. Effect of succinylcholine on plasma potassium in children with cerebral palsy. , 1985, Anesthesiology.
[25] M Milner,et al. Oral motor functioning, frequency of swallowing and drooling in normal children and in children with cerebral palsy. , 1986, Archives of physical medicine and rehabilitation.
[26] R. Goldschmidt,et al. ‘Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation? , 1998, Developmental medicine and child neurology.
[27] J. Dormans,et al. Intraoperative anaphylaxis due to allergy to latex in children who have cerebral palsy: a report of six cases , 1997, Developmental medicine and child neurology.
[28] J. McLaughlin,et al. Pain management for children following selective dorsal rhizotomy , 1994, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[29] M. Curzon,et al. The prevalence of malocclusion in children with cerebral palsy. , 1996, European journal of orthodontics.
[30] K. Biersdorff. Incidence of significantly altered pain experience among individuals with developmental disabilities. , 1994, American journal of mental retardation : AJMR.
[31] G. Molenaers,et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. , 2000, Gait & posture.
[32] F. Shann. Paracetamol: use in children , 1995 .
[33] E. Alberman,et al. Cerebral palsy: why we must plan for survival. , 1990, Archives of disease in childhood.
[34] R. Robinson. The Frequency of Other Handicaps in Children with Cerebal Palsy , 1973, Developmental medicine and child neurology.
[35] M. Kahana,et al. Intrathecal morphine for postoperative analgesia in children after selective dorsal root rhizotomy. , 1991, Neurosurgery.
[36] D. Dressler,et al. Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[37] P. Southorn,et al. Bradycardia and hypotension associated with baclofen used during general anesthesia. , 1986, Anesthesiology.
[38] M. Bax. TERMINOLOGY AND CLASSIFICATION OF CEREBRAL PALSY , 1964, Developmental medicine and child neurology.
[39] E. Brunner,et al. Inducing Anesthesia with a GABA Analog, THIP , 1985, Anesthesiology.
[40] P. McGrath,et al. Behaviours caregivers use to determine pain in non‐verbal, cognitively impaired individuals , 1998, Developmental medicine and child neurology.